fbpx
October 5, 2020

Promise Pharmacy, LLC – 587148 – 07/29/2019

Delivery Method: UPS Product: Drugs Recipient: Recipient Name Dipti V. Patel Recipient Title Owner Promise Pharmacy, LLC 31818 US Highway 19 NPalm Harbor, FL 34684-3713United States […]
October 5, 2020

TG United, Inc. – 577583 – 08/01/2019

Delivery Method: VIA UPS Product: Drugs Recipient: Recipient Name Mr. David Ambrose Recipient Title CEO/Owner TG United, Inc. 16275 Aviation Loop DriveBrooksville, FL 34604-6805United States Issuing […]
October 5, 2020

Let’s Talk Health, Inc. – 576771 – 08/06/2019

Delivery Method: VIA UPS Product: Drugs Recipient: Recipient Name Mr. James L. Cartmill Recipient Title President Let’s Talk Health, Inc. 2411 Fenton St. Ste 102Chula Vista, […]
October 5, 2020

NingBo Huize Commodity Co., Ltd. – 581345 – 08/02/2019

Delivery Method: VIA UPS Product: Drugs Recipient: Recipient Name Mr. Wenxuan Han Recipient Title General Manager/Owner NingBo Huize Commodity Co., Ltd. 14 Lizhou Road Yuyao, ZhejiangZhejiang […]
October 5, 2020

University Rx Specialists Inc – 495985 – 12/11/2018

Delivery Method: SIGNATURE CONFIRMED DELIVERY Product: Drugs Recipient: Recipient Name Joseph Grasela, RPh Recipient Title President/Owner University Rx Specialists Inc University Compounding Pharmacy 1875 3rd AvenueSan […]
October 2, 2020

Coronavirus (COVID-19) Update: Daily Roundup October 2, 2020

For Immediate Release: October 02, 2020 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 […]
October 2, 2020

Ashtel Studios Issues Voluntary Recall of Licensed Hand Sanitizers Packaged in 0.84 Fluid Ounce Pouches Due to Misbranding Because They Resemble Food and Drink Container Pouches

Summary Company Announcement Date: October 01, 2020 FDA Publish Date: October 02, 2020 Product Type: Drugs Reason for Announcement: Recall Reason Description Product is packaged in […]
October 2, 2020

FDA approves nivolumab and ipilimumab for unresectable malignant pleural mesothelioma

On October 2, 2020, the Food and Drug Administration approved the combination of nivolumab (OPDIVO, Bristol-Myers Squibb Co.) plus ipilimumab (YERVOY, Bristol-Myers Squibb Co.) as first-line […]
October 2, 2020

12th Annual Sentinel Initiative Public Workshop – 10/14/2020 – 10/14/2020

On This Page Date: October 14, 2020 Time: 1:00 PM – 4:00 PM ET 12th ANNUAL FDA SENTINEL PUBLIC WORKSHOP The Sentinel Initiative, an active medical […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0